Selective	O
expression	O
of	O
an	O
interleukin-12	B-protein
receptor	I-protein
component	I-protein
by	O
human	B-cell_type
T	I-cell_type
helper	I-cell_type
1	I-cell_type
cells	I-cell_type
.	O

Interleukin-12	B-protein
(	O
IL-12	B-protein
)	O
,	O
a	O
heterodimeric	B-protein
cytokine	I-protein
produced	O
by	O
activated	O
monocytes	O
and	O
dendritic	O
cells	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
interferon	B-protein
(	I-protein
IFN	I-protein
)	I-protein
-gamma	I-protein
production	O
and	O
in	O
the	O
generation	O
of	O
IFN-gamma-producing	B-cell_type
T	I-cell_type
helper	I-cell_type
1	I-cell_type
(	I-cell_type
Th1	I-cell_type
)	I-cell_type
cells	I-cell_type
.	O

Here	O
we	O
show	O
that	O
the	O
IL-12	B-protein
receptor	I-protein
(	I-protein
IL-12R	I-protein
)	I-protein
beta	I-protein
2	I-protein
subunit	I-protein
,	O
a	O
recently	O
cloned	O
binding	B-protein
and	I-protein
signal	I-protein
transducing	I-protein
component	I-protein
of	O
the	O
IL-12R	B-protein
,	O
is	O
expressed	O
on	O
human	B-cell_line
Th1	I-cell_line
but	I-cell_line
not	I-cell_line
Th2	I-cell_line
clones	I-cell_line
and	O
is	O
induced	O
during	O
differentiation	O
of	O
human	B-cell_type
naive	I-cell_type
cells	I-cell_type
along	O
the	O
Th1	O
but	O
not	O
the	O
Th2	O
pathway	O
.	O

IL-12	B-protein
and	O
type	B-protein
I	I-protein
but	I-protein
not	I-protein
type	I-protein
II	I-protein
interferons	I-protein
induce	O
expression	O
of	O
the	O
IL-12R	B-protein
beta	I-protein
2	I-protein
chain	I-protein
during	O
in	O
vitro	O
T	O
cell	O
differentiation	O
after	O
antigen	O
receptor	O
triggering	O
.	O

The	O
selective	O
expression	O
and	O
regulation	O
of	O
the	O
IL-12R	B-protein
beta	I-protein
2	I-protein
subunit	I-protein
may	O
help	O
to	O
understand	O
the	O
basis	O
of	O
Th1/Th2	O
differentiation	O
and	O
may	O
provide	O
therapeutic	O
options	O
for	O
altering	O
the	O
Th1/Th2	O
balance	O
in	O
several	O
immuno-pathological	O
conditions	O
such	O
as	O
autoimmune	O
diseases	O
and	O
allergies	O
.	O

Selective	NULL
Expression	NULL
of	NULL
an	NULL
Interleukin-12	NULL
Receptor	NULL
Component	NULL
by	NULL
Human	NULL
T	NULL
Helper	NULL
1	NULL
Cells	NULL
By	NULL
Lars	NULL
R	NULL
ogge	NULL
,	NULL
*	NULL
Luisella	NULL
Barberis	NULL
Maino	NULL
,	NULL
*	NULL
Mauro	NULL
Biffi	NULL
,	NULL
*	NULL
Nadia	NULL
Passini	NULL
,	NULL
*	NULL
David	NULL
H.	NULL
Presky	NULL
,	NULL
*	NULL
U	NULL
eli	NULL
Gubler	NULL
,	NULL
*	NULL
and	NULL
Francesco	NULL
Sinigaglia*	NULL
From	NULL
*R	NULL
oche	NULL
Milano	NULL
Ricerche	NULL
1-20132	NULL
Milan	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Inflammation/	NULL
Autoimmune	NULL
Diseases	NULL
Hoffmann-La	NULL
R	NULL
oche	NULL
Inc	NULL
,	NULL
N	NULL
utley	NULL
,	NULL
N	NULL
ew	NULL
Jersey	NULL
07110	NULL
Sum	NULL
m	NULL
ary	NULL
Interleukin-12	NULL
(	NULL
IL-12	NULL
)	NULL
,	NULL
a	NULL
heterodimeric	NULL
cytokine	NULL
produced	NULL
by	NULL
activated	NULL
monocytes	NULL
and	NULL
den-dritic	NULL
cells	NULL
,	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
regulating	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
-y	NULL
production	NULL
and	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
IFN-y-producing	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
IL-12	NULL
receptor	NULL
(	NULL
IL-12R	NULL
)	NULL
B2	NULL
subunit	NULL
,	NULL
a	NULL
recently	NULL
cloned	NULL
binding	NULL
and	NULL
signal	NULL
transducing	NULL
component	NULL
of	NULL
the	NULL
IL-	NULL
12R	NULL
,	NULL
is	NULL
expressed	NULL
on	NULL
human	NULL
Th1	NULL
but	NULL
not	NULL
Th2	NULL
clones	NULL
and	NULL
is	NULL
induced	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
naive	NULL
cells	NULL
along	NULL
the	NULL
Th1	NULL
but	NULL
not	NULL
the	NULL
Th2	NULL
pathway	NULL
.	NULL

IL-	NULL
12	NULL
and	NULL
type	NULL
I	NULL
but	NULL
not	NULL
type	NULL
II	NULL
interferons	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
IL-	NULL
12R	NULL
B2	NULL
chain	NULL
during	NULL
in	NULL
vitro	NULL
T	NULL
cell	NULL
differentiation	NULL
after	NULL
antigen	NULL
receptor	NULL
triggering	NULL
.	NULL

The	NULL
selective	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
may	NULL
help	NULL
to	NULL
understand	NULL
the	NULL
basis	NULL
of	NULL
Th1/	NULL
Th2	NULL
differentiation	NULL
and	NULL
may	NULL
provide	NULL
therapeutic	NULL
options	NULL
for	NULL
altering	NULL
the	NULL
Th1/Th2	NULL
balance	NULL
in	NULL
several	NULL
immuno-pathological	NULL
conditions	NULL
such	NULL
as	NULL
autoimmune	NULL
diseases	NULL
and	NULL
allergies	NULL
.	NULL

D4*	NULL
T	NULL
helper	NULL
cells	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
three	NULL
major	NULL
subsets	NULL
termed	NULL
Th1	NULL
,	NULL
Th2	NULL
,	NULL
and	NULL
ThQ	NULL
,	NULL
based	NULL
on	NULL
the	NULL
pattern	NULL
of	NULL
lymphokines	NULL
they	NULL
produce	NULL
.	NULL

Th1	NULL
cells	NULL
produce	NULL
IFN-y	NULL
and	NULL
predominantly	NULL
promote	NULL
cell-mediated	NULL
immune	NULL
re-sponses	NULL
,	NULL
whereas	NULL
Th2	NULL
cells	NULL
,	NULL
which	NULL
produce	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
,	NULL
provide	NULL
help	NULL
for	NULL
some	NULL
B	NULL
cell	NULL
responses	NULL
.	NULL

IL-4	NULL
in	NULL
particular	NULL
is	NULL
the	NULL
major	NULL
inducer	NULL
of	NULL
B	NULL
cell	NULL
switching	NULL
to	NULL
IgE	NULL
production	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
therefore	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
allergic	NULL
reactions	NULL
involving	NULL
IgE	NULL
and	NULL
mast	NULL
cells	NULL
Th	NULL
cells	NULL
producing	NULL
cytokines	NULL
typical	NULL
of	NULL
both	NULL
Thl1	NULL
and	NULL
Th2	NULL
clones	NULL
have	NULL
also	NULL
been	NULL
described	NULL
in	NULL
both	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
system	NULL
,	NULL
and	NULL
they	NULL
have	NULL
been	NULL
named	NULL
ThO	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
development	NULL
of	NULL
these	NULL
subsets	NULL
is	NULL
a	NULL
major	NULL
determinant	NULL
of	NULL
the	NULL
outcome	NULL
of	NULL
physiological	NULL
,	NULL
as	NULL
well	NULL
as	NULL
pathological	NULL
,	NULL
immune	NULL
responses	NULL
including	NULL
autoimmune	NULL
,	NULL
allergic	NULL
,	NULL
and	NULL
infectious	NULL
diseases	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
understanding	NULL
the	NULL
mechanisms	NULL
underlying	NULL
Th	NULL
cell	NULL
differentiation	NULL
is	NULL
essential	NULL
for	NULL
therapeutic	NULL
manipulation	NULL
of	NULL
the	NULL
cytokine	NULL
phenotype	NULL
in	NULL
disease	NULL
conditions	NULL
.	NULL

Differentiation	NULL
towards	NULL
the	NULL
Th1	NULL
or	NULL
Th2	NULL
phenotype	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
directed	NULL
by	NULL
exogenous	NULL
cytokines	NULL
present	NULL
at	NULL
the	NULL
time	NULL
of	NULL
antigen	NULL
exposure	NULL
.	NULL

IL-4	NULL
promotes	NULL
Th2	NULL
development	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
IL-	NULL
12	NULL
produced	NULL
by	NULL
APCs	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
Th1	NULL
cells	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
necessity	NULL
of	NULL
IL-12	NULL
for	NULL
induction	NULL
of	NULL
Th1	NULL
cell	NULL
differentiation	NULL
is	NULL
the	NULL
finding	NULL
that	NULL
IL-12	NULL
p40-'~	NULL
mice	NULL
are	NULL
defective	NULL
in	NULL
IFN-y	NULL
production	NULL
and	NULL
almost	NULL
completely	NULL
lack	NULL
the	NULL
ability	NULL
to	NULL
generate	NULL
a	NULL
Th1	NULL
response	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
knockout	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
resulted	NULL
in	NULL
deficient	NULL
Th2	NULL
responses	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
crucial	NULL
role	NULL
of	NULL
IL-	NULL
12	NULL
and	NULL
IL-4	NULL
signaling	NULL
in	NULL
the	NULL
differen-	NULL
tiation	NULL
of	NULL
Th	NULL
subsets	NULL
has	NULL
been	NULL
analyzed	NULL
more	NULL
recently	NULL
in	NULL
mice	NULL
deficient	NULL
in	NULL
the	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
6	NULL
and	NULL
4	NULL
(	NULL
Stat6	NULL
and	NULL
Stat4	NULL
)	NULL
'	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
thought	NULL
to	NULL
mediate	NULL
functional	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
IL-	NULL
12	NULL
,	NULL
respectively	NULL
.	NULL

Stat6-deficient	NULL
T	NULL
lymphocytes	NULL
fail	NULL
to	NULL
differentiate	NULL
into	NULL
Th2	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
(	NULL
13-15	NULL
)	NULL
,	NULL
and	NULL
the	NULL
analysis	NULL
of	NULL
Stat4-	NULL
'	NULL
-	NULL
T	NULL
cells	NULL
revealed	NULL
an	NULL
impaired	NULL
production	NULL
of	NULL
IFN-y	NULL
upon	NULL
antigen	NULL
triggering	NULL
,	NULL
indicative	NULL
of	NULL
a	NULL
defect	NULL
in	NULL
Th1	NULL
differentiation	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
paper	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
IL-12	NULL
signaling	NULL
and	NULL
IL-12	NULL
receptor	NULL
expression	NULL
and	NULL
regulation	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
the	NULL
Th1	NULL
and	NULL
the	NULL
Th2	NULL
subsets	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
in	NULL
the	NULL
murine	NULL
system	NULL
,	NULL
IL-	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Stat4	NULL
in	NULL
human	NULL
Th1	NULL
,	NULL
but	NULL
not	NULL
Th2	NULL
cells	NULL
IL-12-dependent	NULL
signaling	NULL
in	NULL
human	NULL
Th1	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
selective	NULL
expression	NULL
of	NULL
the	NULL
transcripts	NULL
encoding	NULL
the	NULL
signaling	NULL
component	NULL
of	NULL
the	NULL
IL-12	NULL
receptor	NULL
(	NULL
IL-	NULL
)	NULL
B2	NULL
and	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
high	NULL
affinity	NULL
IL-	NULL
12	NULL
binding	NULL
sites	NULL
selectively	NULL
on	NULL
Th1	NULL
cells	NULL
.	NULL

IL-12R	NULL
B2	NULL
transcripts	NULL
,	NULL
which	NULL
were	NULL
absent	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
were	NULL
found	NULL
as	NULL
early	NULL
as	NULL
24	NULL
h	NULL
after	NULL
mitogen	NULL
stimulation	NULL
.	NULL

IL-	NULL
12	NULL
and	NULL
type	NULL
I	NULL
but	NULL
not	NULL
type	NULL
II	NULL
IFN	NULL
s	NULL
induce	NULL
expression	NULL
of	NULL
IL-	NULL
12R	NULL
B2	NULL
mRNAs	NULL
,	NULL
whereas	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
cells	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
.	NULL

The	NULL
selective	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
IL-12	NULL
receptor	NULL
B2	NULL
!	NULL

A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
IL-	NULL
12R	NULL
,	NULL
IL-12	NULL
receptor	NULL
;	NULL
Stat	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

825	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/97/	NULL
03/	NULL
825/07	NULL
$	NULL
2.00	NULL
Volume	NULL
185	NULL
,	NULL
Number	NULL
5	NULL
,	NULL
March	NULL
3	NULL
,	NULL
1997	NULL
825-831	NULL
subunit	NULL
may	NULL
help	NULL
understand	NULL
the	NULL
molecular	NULL
events	NULL
controlling	NULL
Th	NULL
cell	NULL
development	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Generation	NULL
of	NULL
Thl	NULL
and	NULL
Th2	NULL
Lines	NULL
from	NULL
Cord	NULL
Blood	NULL
Leukocytes	NULL
.	NULL

Human	NULL
neonatal	NULL
leukocytes	NULL
were	NULL
isolated	NULL
from	NULL
freshly	NULL
collected	NULL
,	NULL
heparinized	NULL
,	NULL
neonatal	NULL
blood	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
AB	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Neonatal	NULL
T	NULL
cell	NULL
preparations	NULL
were	NULL
>	NULL
70	NULL
%	NULL
CD45RA*	NULL
and	NULL
50-60	NULL
%	NULL
CD4*	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
stimulating	NULL
cord	NULL
blood	NULL
leukocytes	NULL
with	NULL
2	NULL
g/ml	NULL
PHA	NULL
(	NULL
Wellcome	NULL
,	NULL
Becken-ham	NULL
,	NULL
UK	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ng/ml	NULL
IL-12	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
Inc.	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
200	NULL
ng/ml	NULL
neutralizing	NULL
anti-IL-4	NULL
antibodies	NULL
(	NULL
No	NULL
.	NULL

18500D	NULL
;	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
Th1	NULL
cultures	NULL
,	NULL
or	NULL
200	NULL
U/	NULL
ml	NULL
IL-4	NULL
(	NULL
PharMingen	NULL
)	NULL
and	NULL
2	NULL
g/	NULL
ml	NULL
neutralizing	NULL
anti-IL-12	NULL
antibodies	NULL
17F7	NULL
and	NULL
20C2	NULL
(	NULL
provided	NULL
by	NULL
M.	NULL
Gately	NULL
,	NULL
Hoffmann-La	NULL
R	NULL
oche	NULL
Inc.	NULL
)	NULL
for	NULL
Th2	NULL
cultures	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
cord	NULL
blood-derived	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
60-90	NULL
%	NULL
CD4*	NULL
.	NULL

The	NULL
remaining	NULL
cells	NULL
were	NULL
CD8*	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
on	NULL
day	NULL
3	NULL
and	NULL
expanded	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
100	NULL
U/	NULL
ml	NULL
pen-icillin-streptomycin	NULL
,	NULL
and	NULL
containing	NULL
100	NULL
U/ml	NULL
IL-2	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
Inc.	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
again	NULL
on	NULL
day	NULL
10	NULL
and	NULL
10°	NULL
cells	NULL
were	NULL
restimulated	NULL
in	NULL
96-well	NULL
round-bottom	NULL
plates	NULL
for	NULL
24	NULL
h	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
antibodies	NULL
(	NULL
clone	NULL
TR	NULL
66	NULL
;	NULL
reference	NULL
19	NULL
)	NULL
to	NULL
measure	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
in	NULL
culture	NULL
supernatants	NULL
by	NULL
ELISA	NULL
assays	NULL
(	NULL
provided	NULL
by	NULL
H.	NULL
Gallati	NULL
,	NULL
F.	NULL
Hoffmann-La	NULL
Roche	NULL
AG	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
;	NULL
reference	NULL
20	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
effects	NULL
of	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
interferons	NULL
on	NULL
T	NULL
helper	NULL
cell	NULL
differentiation	NULL
,	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
stimulating	NULL
cord	NULL
blood	NULL
leukocytes	NULL
with	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
or	NULL
anti-cytokine	NULL
antibodies	NULL
as	NULL
above	NULL
.	NULL

IFN-a	NULL
«	NULL
or	NULL
IFN-y	NULL
(	NULL
1,000	NULL
U/ml	NULL
;	NULL
F.	NULL
Hoffmann-La	NULL
Roche	NULL
AG	NULL
)	NULL
were	NULL
added	NULL
at	NULL
the	NULL
time	NULL
of	NULL
priming	NULL
to	NULL
the	NULL
cultures	NULL
.	NULL

Cytokine	NULL
production	NULL
was	NULL
determined	NULL
on	NULL
day	NULL
10	NULL
as	NULL
above	NULL
.	NULL

Purification	NULL
and	NULL
Stimulation	NULL
of	NULL
CD45SRA	NULL
*	NULL
T	NULL
Cells	NULL
PBMCs	NULL
were	NULL
isolated	NULL
from	NULL
human	NULL
blood	NULL
buffy	NULL
coats	NULL
from	NULL
healthy	NULL
donors	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
AB	NULL
)	NULL
density	NULL
gradient	NULL
centrifu-gation	NULL
.	NULL

Monocytes	NULL
were	NULL
depleted	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
plastic	NULL
adherence	NULL
and	NULL
B	NULL
cells	NULL
were	NULL
depleted	NULL
by	NULL
adherence	NULL
to	NULL
nylon	NULL
wool	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

CD45R	NULL
A*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
immunomagnetic	NULL
negative	NULL
selection	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
the	NULL
following	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
anti-CD16	NULL
(	NULL
B73.1	NULL
;	NULL
reference	NULL
21	NULL
)	NULL
,	NULL
anti-CD45RO	NULL
(	NULL
UCHL-1	NULL
;	NULL
reference	NULL
22	NULL
)	NULL
and	NULL
anti-HLA-DR	NULL
(	NULL
1-1C4	NULL
;	NULL
reference	NULL
23	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
incubated	NULL
with	NULL
goat	NULL
anti-mouse	NULL
IgG-coated	NULL
Dynabeads	NULL
(	NULL
Dynal	NULL
,	NULL
Inc.	NULL
,	NULL
Geat	NULL
Neck	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
a	NULL
magnetic	NULL
field	NULL
using	NULL
a	NULL
magnetic	NULL
particle	NULL
concentra-tor	NULL
(	NULL
Dynal	NULL
,	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
CD3/	NULL
CD4SR	NULL
A*	NULL
T	NULL
cells	NULL
using	NULL
this	NULL
procedure	NULL
was	NULL
typically	NULL
>	NULL
98	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Purified	NULL
CD4SR	NULL
A*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAbs	NULL
(	NULL
TR	NULL
66	NULL
;	NULL
reference	NULL
19	NULL
)	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
cytokines	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-	NULL
12	NULL
(	NULL
2	NULL
ng/	NULL
mI	NULL
)	NULL
or	NULL
IL-4	NULL
(	NULL
200	NULL
U/	NULL
mJ	NULL
)	NULL
.	NULL

T	NULL
Cell	NULL
Clones	NULL
.	NULL

Thl	NULL
and	NULL
Th2	NULL
cells	NULL
generated	NULL
from	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
were	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
0.3	NULL
celly	NULL
well	NULL
were	NULL
plated	NULL
in	NULL
96-well	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
irradiated	NULL
(	NULL
5,000	NULL
rads	NULL
)	NULL
allogeneic	NULL
PBMCs	NULL
,	NULL
PHA	NULL
(	NULL
2	NULL
g/	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
IL-2	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Positive	NULL
wells	NULL
were	NULL
restimulated	NULL
and	NULL
expanded	NULL
and	NULL
cytokine	NULL
production	NULL
of	NULL
individual	NULL
clones	NULL
was	NULL
measured	NULL
as	NULL
above	NULL
.	NULL

Three	NULL
T	NULL
cell	NULL
clones	NULL
that	NULL
produced	NULL
IFN-y	NULL
but	NULL
not	NULL
IL-4	NULL
were	NULL
categorized	NULL
as	NULL
Th1	NULL
,	NULL
and	NULL
five	NULL
T	NULL
cell	NULL
clones	NULL
able	NULL
to	NULL
produce	NULL
IL-4	NULL
but	NULL
not	NULL
IFN-y	NULL
were	NULL
categorized	NULL
as	NULL
Th2	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
Extrads	NULL
,	NULL
Immunopredpitations	NULL
,	NULL
and	NULL
Westem	NULL
Blot	NULL
Analysis	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
lines	NULL
generated	NULL
from	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
10	NULL
after	NULL
priming	NULL
.	NULL

Th1	NULL
(	NULL
CB13	NULL
)	NULL
and	NULL
Th2	NULL
(	NULL
CB21	NULL
)	NULL
clones	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
13	NULL
after	NULL
restimulation	NULL
.	NULL

5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
1	NULL
ml	NULL
RPMI	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ng/	NULL
ml	NULL
IL-12	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
before	NULL
lysing	NULL
the	NULL
cell	NULL
pellet	NULL
in	NULL
250	NULL
pu	NULL
IP	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
HCI	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
0.25	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
10	NULL
g/	NULL
ml	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
AEBSF	NULL
and	NULL
sodium	NULL
ortho-vanadate	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
incubated	NULL
30	NULL
min	NULL
on	NULL
a	NULL
shaker	NULL
at	NULL
4°C	NULL
and	NULL
insoluble	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
(	NULL
13,000	NULL
rpm	NULL
,	NULL
4°C	NULL
,	NULL
30	NULL
min	NULL
)	NULL
.	NULL

Stat4	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
anti-	NULL
Stat4	NULL
antisera	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

After	NULL
transfer	NULL
to	NULL
nitrocellulose	NULL
,	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
immunoreactive	NULL
bands	NULL
were	NULL
visualized	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
Western	NULL
blotting	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
company	NULL
's	NULL
protocols	NULL
.	NULL

To	NULL
control	NULL
for	NULL
equal	NULL
protein	NULL
loading	NULL
,	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-	NULL
Stat4	NULL
antisera	NULL
.	NULL

Ribonudease	NULL
Protection	NULL
Assays	NULL
.	NULL

A	NULL
327-bp	NULL
DNA	NULL
fragment	NULL
encompassing	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
(	NULL
25	NULL
)	NULL
and	NULL
a	NULL
553-bp	NULL
EcoR	NULL
I/	NULL
BamHI	NULL
fragment	NULL
derived	NULL
from	NULL
the	NULL
IL-12R	NULL
B1	NULL
cDNA	NULL
(	NULL
26	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
pGEM	NULL
3Z	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
linearized	NULL
with	NULL
EcoRI	NULL
and	NULL
radiolabeled	NULL
antisense	NULL
transcripts	NULL
were	NULL
synthesized	NULL
with	NULL
SP6	NULL
polymerase	NULL
and	NULL
a	NULL
commercial	NULL
kit	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
or	NULL
clones	NULL
using	NULL
UlItraspec	NULL
total	NULL
RNA	NULL
extraction	NULL
reagent	NULL
(	NULL
Biotecx	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
as	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
RNA	NULL
probes	NULL
were	NULL
hybridized	NULL
to	NULL
10	NULL
jg	NULL
total	NULL
RNA	NULL
and	NULL
ribonuclease	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Ambion	NULL
Inc.	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
according	NULL
to	NULL
the	NULL
company	NULL
's	NULL
protocol	NULL
.	NULL

Products	NULL
were	NULL
resolved	NULL
on	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
the	NULL
protected	NULL
fragments	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
radioactivity	NULL
present	NULL
in	NULL
the	NULL
protected	NULL
fragments	NULL
was	NULL
also	NULL
quantitated	NULL
using	NULL
a	NULL
MolecularImager	NULL
(	NULL
Bio-Rad	NULL
Labs	NULL
.	NULL

,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

An	NULL
188	NULL
RNA	NULL
probe	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
equal	NULL
RNA	NULL
loading	NULL
.	NULL

Saitchard	NULL
Analysis	NULL
of	NULL
[	NULL
I	NULL
JIL-12	NULL
Binding	NULL
to	NULL
Human	NULL
Th1	NULL
and	NULL
Th2	NULL
Céll	NULL
Lines	NULL
.	NULL

Thl	NULL
and	NULL
Th2	NULL
lines	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

[	NULL
``	NULL
IJIL-12	NULL
binding	NULL
to	NULL
human	NULL
Thl1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
was	NULL
analyzed	NULL
using	NULL
the	NULL
LIGAND	NULL
program	NULL
(	NULL
29	NULL
)	NULL
and	NULL
plotted	NULL
by	NULL
the	NULL
Scatchard	NULL
method	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
IL-12	NULL
Induces	NULL
Stat4	NULL
Phosphorylation	NULL
in	NULL
Human	NULL
Th1	NULL
but	NULL
N	NULL
ot	NULL
Th2	NULL
Cells	NULL
To	NULL
characterize	NULL
the	NULL
role	NULL
of	NULL
IL-12	NULL
and	NULL
other	NULL
cytokines	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
,	NULL
we	NULL
have	NULL
generated	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
by	NULL
stimulating	NULL
human	NULL
cord	NULL
blood	NULL
leukocytes	NULL
with	NULL
mitogen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
,	NULL
and	NULL
neutralizing	NULL
anti-IL-4	NULL
mAb	NULL
or	NULL
IL-4	NULL
,	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAb	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
protocol	NULL
allows	NULL
the	NULL
establishment	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
with	NULL
strongly	NULL
polarized	NULL
cytokine	NULL
production	NULL
.	NULL

Neonatal	NULL
T	NULL
cells	NULL
primed	NULL
under	NULL
the	NULL
Th1	NULL
conditions	NULL
produced	NULL
up	NULL
to	NULL
2	NULL
ng/	NULL
ml	NULL
of	NULL
IFN-y	NULL
and	NULL
<	NULL
0.2	NULL
ng/	NULL
ml	NULL
IL-4	NULL
upon	NULL
restimulation	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
,	NULL
whereas	NULL
neonatal	NULL
T	NULL
cells	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
anti-IL-	NULL
12	NULL
mAb	NULL
produced	NULL
1.2	NULL
ng/	NULL
ml	NULL
826	NULL
_	NULL
Expression	NULL
of	NULL
IL-12	NULL
Receptors	NULL
during	NULL
T	NULL
Helper	NULL
Subset	NULL
Differentiation	NULL
Thi	NULL
line	NULL
Th2	NULL
line	NULL
2.0	NULL
1.6	NULL
1.2	NULL
0.8	NULL
04	NULL
0	NULL
04	NULL
0.8	NULL
1.2	NULL
IFN-y	NULL
ng/ml	NULL
IL-4	NULL
ng/ml	NULL
B	NULL
CB13	NULL
CB21	NULL
2.0	NULL
15	NULL
1.0	NULL
05	NULL
0	NULL
1.0	NULL
20	NULL
3.0	NULL
4.0	NULL
IFN-y	NULL
ng/m	NULL
!	NULL

IL-4	NULL
ng/ml	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
Cytokine	NULL
profiles	NULL
of	NULL
cord	NULL
blood	NULL
derived	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
and	NULL
of	NULL
established	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
production	NULL
by	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
generated	NULL
from	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
Cells	NULL
were	NULL
washed	NULL
on	NULL
day	NULL
10	NULL
after	NULL
priming	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
restimulated	NULL
in	NULL
96-well	NULL
round-bottom	NULL
plates	NULL
for	NULL
24	NULL
h	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
antibodies	NULL
(	NULL
clone	NULL
TR	NULL
66	NULL
;	NULL
reference	NULL
19	NULL
)	NULL
,	NULL
to	NULL
determine	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
in	NULL
culture	NULL
supernatants	NULL
by	NULL
ELISA	NULL
assays	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
production	NULL
by	NULL
established	NULL
Th1	NULL
(	NULL
CB13	NULL
)	NULL
and	NULL
Th2	NULL
(	NULL
CB21	NULL
)	NULL
clones	NULL
.	NULL

of	NULL
IL-4	NULL
and	NULL
<	NULL
0.02	NULL
ng/ml	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

Subsequent	NULL
cloning	NULL
of	NULL
the	NULL
Th1	NULL
and	NULL
the	NULL
Th2	NULL
lines	NULL
resulted	NULL
in	NULL
a	NULL
series	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
with	NULL
either	NULL
a	NULL
Th1	NULL
or	NULL
a	NULL
Th2	NULL
polarized	NULL
cytokine	NULL
profile	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
murine	NULL
TCR	NULL
trans	NULL
genic	NULL
system	NULL
,	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

observed	NULL
that	NULL
IL-12	NULL
selectively	NULL
activated	NULL
the	NULL
Janus	NULL
kinase	NULL
Jak2	NULL
,	NULL
and	NULL
the	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
Stat3	NULL
and	NULL
Stat4	NULL
in	NULL
Th1	NULL
,	NULL
but	NULL
not	NULL
in	NULL
differentiated	NULL
Th2	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
ascertain	NULL
whether	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
subsets	NULL
also	NULL
differ	NULL
in	NULL
IL-12	NULL
signaling	NULL
,	NULL
we	NULL
examined	NULL
Stat4	NULL
expression	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-	NULL
12	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
and	NULL
clones	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
IL-12	NULL
treatment	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat4	NULL
selectively	NULL
in	NULL
Th1	NULL
but	NULL
not	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
although	NULL
both	NULL
cell	NULL
types	NULL
expressed	NULL
comparable	NULL
amounts	NULL
of	NULL
the	NULL
Stat4	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
bottom	NULL
)	NULL
required	NULL
for	NULL
IL-12	NULL
signaling	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
after	NULL
IL-	NULL
12	NULL
stimulation	NULL
,	NULL
Jak2	NULL
(	NULL
33	NULL
)	NULL
,	NULL
which	NULL
was	NULL
also	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
,	NULL
was	NULL
phosphorylated	NULL
only	NULL
in	NULL
Th1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Selective	NULL
Expression	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
Chain	NULL
in	NULL
Thl	NULL
Cells	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
the	NULL
defect	NULL
in	NULL
IL-12	NULL
signaling	NULL
observed	NULL
in	NULL
Th2	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
a	NULL
differential	NULL
expression	NULL
of	NULL
IL-12	NULL
receptors	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

To	NULL
date	NULL
,	NULL
two	NULL
IL-	NULL
12R	NULL
subunits	NULL
,	NULL
termed	NULL
B1	NULL
and	NULL
B2	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

IL-12R	NULL
B1	NULL
or	NULL
B2	NULL
,	NULL
independently	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
,	NULL
bind	NULL
human	NULL
IL-12	NULL
with	NULL
low	NULL
affinity	NULL
(	NULL
Kp	NULL
=	NULL
3-5	NULL
nM	NULL
)	NULL
,	NULL
whereas	NULL
coexpres	NULL
sion	NULL
of	NULL
IL-12R	NULL
B1	NULL
and	NULL
B2	NULL
in	NULL
COS	NULL
cells	NULL
gives	NULL
rise	NULL
to	NULL
high	NULL
827	NULL
_	NULL
Rogge	NULL
et	NULL
al	NULL
.	NULL

Thi	NULL
-	NULL
Th2	NULL
CB13	NULL
CB21	NULL
oT	NULL
ETN	NULL
O	NULL
E	NULL
L422	NULL
Blot	NULL
:	NULL
waee	NULL
sway	NULL
anti-P-¥	NULL
IP	NULL
:	NULL
anti-Statd4	NULL
wo	NULL
S5	NULL
gan	NULL
ose	NULL
.	NULL

game	NULL
OB	NULL
a	NULL
aan	NULL
ANt-StAlL	NULL
102	NULL
3	NULL
40	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
IL-12-dependent	NULL
signaling	NULL
in	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
and	NULL
clones	NULL
.	NULL

IL-12	NULL
induces	NULL
Stat4	NULL
phosphorylation	NULL
in	NULL
human	NULL
Th1	NULL
but	NULL
not	NULL
Th2	NULL
cells	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
generated	NULL
from	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
10	NULL
after	NULL
priming	NULL
.	NULL

Th1	NULL
(	NULL
CB13	NULL
)	NULL
and	NULL
Th2	NULL
(	NULL
CB21	NULL
)	NULL
clones	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
13	NULL
after	NULL
restimulation	NULL
.	NULL

5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ng/	NULL
ml	NULL
IL-12	NULL
followed	NULL
by	NULL
the	NULL
preparation	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
and	NULL
im-munoprecipitation	NULL
with	NULL
anti-Stat4	NULL
antiserum	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
8	NULL
%	NULL
)	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
anti-P-¥	NULL
,	NULL
top	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
Stat4	NULL
expression	NULL
,	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Stat4	NULL
antibodies	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

affinity	NULL
binding	NULL
sites	NULL
(	NULL
K	NULL
,	NULL
=	NULL
50	NULL
pm	NULL
)	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
the	NULL
IL-12R	NULL
B2	NULL
is	NULL
the	NULL
signaling	NULL
component	NULL
of	NULL
the	NULL
IL-12R	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
IL-12R	NULL
B2	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
IL-12R	NULL
B1	NULL
,	NULL
contains	NULL
tyrosine	NULL
residues	NULL
in	NULL
its	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
25	NULL
)	NULL
.	NULL

We	NULL
analyzed	NULL
the	NULL
mRNA	NULL
expression	NULL
levels	NULL
for	NULL
the	NULL
IL-12R	NULL
B1	NULL
and	NULL
B2	NULL
subunits	NULL
by	NULL
ribonuclease	NULL
protection	NULL
assays	NULL
in	NULL
both	NULL
Th1l	NULL
and	NULL
Th2	NULL
lines	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
priming	NULL
and	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
clones	NULL
at	NULL
day	NULL
13	NULL
after	NULL
restimulation	NULL
.	NULL

Whereas	NULL
IL-	NULL
12R	NULL
B1	NULL
transcripts	NULL
were	NULL
expressed	NULL
in	NULL
similar	NULL
amounts	NULL
in	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
the	NULL
transcripts	NULL
coding	NULL
for	NULL
the	NULL
IL-	NULL
12R	NULL
B2	NULL
subunit	NULL
were	NULL
selectively	NULL
expressed	NULL
in	NULL
es	NULL
tablished	NULL
Th1	NULL
,	NULL
but	NULL
not	NULL
Th2	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
and	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Maximum	NULL
expression	NULL
in	NULL
Th1	NULL
cells	NULL
was	NULL
seen	NULL
between	NULL
day	NULL
3	NULL
and	NULL
day	NULL
8	NULL
,	NULL
and	NULL
declined	NULL
thereafter	NULL
.	NULL

Th2	NULL
cells	NULL
,	NULL
in	NULL
con	NULL
A	NULL
day	NULL
3	NULL
day5	NULL
day	NULL
8	NULL
day	NULL
21	NULL
day	NULL
19	NULL
*	NULL
i	NULL
*	NULL
¥	NULL
+	NULL
IL-12	NULL
r	NULL
i	NULL
10	NULL
2	NULL
1	NULL
2	NULL
1	NULL
2	NULL
1	NULL
2	NULL
1	NULL
i	NULL
--	NULL
-i	NULL
--	NULL
-i-	NULL
2	NULL
Th	NULL
phenotype	NULL
«	NULL
o	NULL
--	NULL
~	NULL
_.	NULL
ae	NULL
ap	NULL
a	NULL
@	NULL
@	NULL
@	NULL
i	NULL
pi	NULL
B	NULL
CB13	NULL
CB21	NULL
@	NULL
e	NULL
#	NULL
#	NULL
_	NULL
|L-12R	NULL
B2	NULL
-o	NULL
+	NULL
``	NULL
aC	NULL
we	NULL
cw	NULL
em	NULL
me	NULL
(	NULL
31	NULL
;	NULL
;	NULL
;	NULL
«	NULL
-	NULL
a	NULL
»	NULL
IL-12R	NULL
B2	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Transcripts	NULL
encoding	NULL
IL-12	NULL
receptor	NULL
subunits	NULL
in	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
are	NULL
selectively	NULL
expressed	NULL
in	NULL
human	NULL
Th1	NULL
cells	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
generated	NULL
from	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
were	NULL
harvested	NULL
on	NULL
the	NULL
indicated	NULL
time	NULL
after	NULL
priming	NULL
.	NULL

In	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
on	NULL
day	NULL
19	NULL
and	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
medium	NULL
containing	NULL
2	NULL
ng/	NULL
ml	NULL
IL-12	NULL
before	NULL
RNA	NULL
extraction	NULL
on	NULL
day	NULL
21	NULL
.	NULL

Transcripts	NULL
encoding	NULL
the	NULL
IL-12R	NULL
B1	NULL
subunit	NULL
(	NULL
top	NULL
)	NULL
,	NULL
the	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
(	NULL
middle	NULL
)	NULL
and	NULL
an	NULL
188	NULL
RNA	NULL
gene	NULL
fragment	NULL
as	NULL
loading	NULL
control	NULL
(	NULL
bottom	NULL
)	NULL
were	NULL
quantitated	NULL
with	NULL
ribonuclease	NULL
protection	NULL
assays	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
IL-12R	NULL
B1	NULL
and	NULL
B2	NULL
mRNAs	NULL
in	NULL
human	NULL
Th1	NULL
(	NULL
CB13	NULL
)	NULL
and	NULL
Th2	NULL
(	NULL
CB21	NULL
)	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
day	NULL
11	NULL
after	NULL
restimulation	NULL
for	NULL
48	NULL
h	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ng/	NULL
ml	NULL
IL-12	NULL
,	NULL
followed	NULL
by	NULL
RNA	NULL
extraction	NULL
on	NULL
day	NULL
13	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
IL-12R	NULL
B1	NULL
and	NULL
B2	NULL
transcripts	NULL
in	NULL
IL-12	NULL
treated	NULL
and	NULL
untreated	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
R	NULL
Nase	NULL
protection	NULL
assays	NULL
.	NULL

h-+	NULL
g	NULL
6h	NULL
12h	NULL
24h	NULL
48h	NULL
96h	NULL
3	NULL
§	NULL
58	NULL
y	NULL
$	NULL
94	NULL
,	NULL
§	NULL
09	NULL
,	NULL
P	NULL
U	NULL
,	NULL
.	NULL

$	NULL
w	NULL
,	NULL
£	NULL
A8	NULL
§	NULL
a	NULL
a	NULL
§	NULL
4	NULL
3	NULL
§	NULL
4	NULL
3	NULL
§	NULL
J	NULL
a	NULL
§	NULL
a	NULL
a	NULL
-o-	NULL
C	NULL
@	NULL
®	NULL
o	NULL
IL-12R	NULL
B1	NULL
-	NULL
@	NULL
-	NULL
~	NULL
iL-12n	NULL
B2	NULL
99	NULL
!	NULL

!	NULL

!	NULL

’	NULL
9	NULL
'	NULL
.	NULL

``	NULL
``	NULL
``	NULL
'	NULL
1	NULL
%	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
1§	NULL
16	NULL
17	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Antigen	NULL
receptor	NULL
triggering	NULL
induces	NULL
expression	NULL
of	NULL
IL-12R	NULL
B1	NULL
and	NULL
B2	NULL
mRNAs	NULL
in	NULL
purified	NULL
CD45RA*	NULL
T	NULL
cells	NULL
CD45RA*	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
from	NULL
buffy	NULL
coats	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Purified	NULL
CD45R	NULL
A*	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
with	NULL
or	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
IL-12	NULL
(	NULL
2	NULL
ng/	NULL
ml	NULL
)	NULL
or	NULL
IL-4	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
unstimulated	NULL
CD45R	NULL
A*	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
after	NULL
CD3	NULL
stimulation	NULL
.	NULL

Transcripts	NULL
encoding	NULL
IL-12R	NULL
subunits	NULL
were	NULL
quantitated	NULL
in	NULL
R	NULL
Nase	NULL
protection	NULL
assays	NULL
.	NULL

trast	NULL
,	NULL
expressed	NULL
little	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
on	NULL
day	NULL
3	NULL
,	NULL
and	NULL
none	NULL
were	NULL
detected	NULL
after	NULL
day	NULL
8	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

A	NULL
key	NULL
question	NULL
is	NULL
whether	NULL
cytokine	NULL
signaling	NULL
is	NULL
required	NULL
for	NULL
IL-12R	NULL
induction	NULL
or	NULL
whether	NULL
stimulation	NULL
via	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-12R	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

IL-12R	NULL
transcripts	NULL
were	NULL
therefore	NULL
analyzed	NULL
in	NULL
purified	NULL
CD45R	NULL
A*	NULL
T	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
.	NULL

IL-12R	NULL
transcripts	NULL
were	NULL
not	NULL
found	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
but	NULL
could	NULL
be	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
24	NULL
h	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Priming	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-	NULL
12	NULL
resulted	NULL
in	NULL
enhanced	NULL
expression	NULL
of	NULL
IL-	NULL
12R	NULL
B2	NULL
transcripts	NULL
in	NULL
this	NULL
population	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
13	NULL
)	NULL
;	NULL
priming	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
resulted	NULL
in	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
antigen	NULL
receptor	NULL
triggering	NULL
is	NULL
sufficient	NULL
to	NULL
make	NULL
naive	NULL
T	NULL
cells	NULL
susceptible	NULL
to	NULL
IL-	NULL
12	NULL
signaling	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
IL-12R	NULL
expression	NULL
by	NULL
radioligand	NULL
binding	NULL
assays	NULL
.	NULL

Scatchard	NULL
analysis	NULL
of	NULL
specific	NULL
[	NULL
'	NULL
``	NULL
I	NULL
]	NULL
JIL-12	NULL
binding	NULL
to	NULL
human	NULL
cord	NULL
blood	NULL
derived	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

In	NULL
Th1	NULL
cell	NULL
lines	NULL
,	NULL
both	NULL
high	NULL
(	NULL
Kp	NULL
of	NULL
27	NULL
pM	NULL
,	NULL
140	NULL
sites	NULL
'	NULL
cell	NULL
)	NULL
and	NULL
low	NULL
affinity	NULL
(	NULL
Kp	NULL
,	NULL
of	NULL
5	NULL
nM	NULL
,	NULL
450	NULL
sites	NULL
cell	NULL
)	NULL
[	NULL
!	NULL

°IJIL-12	NULL
binding	NULL
sites	NULL
were	NULL
measured	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Th2	NULL
cells	NULL
lines	NULL
exhibited	NULL
only	NULL
low	NULL
affinity	NULL
[	NULL
!	NULL

``	NULL
IJIL-12	NULL
binding	NULL
sites	NULL
(	NULL
K	NULL
;	NULL
,	NULL
of	NULL
2	NULL
nM	NULL
220	NULL
sites/	NULL
cell	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
measurable	NULL
high	NULL
affinity	NULL
[	NULL
!	NULL

``	NULL
IJIL-12	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
Th2	NULL
cell	NULL
lines	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observed	NULL
lack	NULL
of	NULL
IL-12R	NULL
B2	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
On	NULL
the	NULL
contrary	NULL
,	NULL
similar	NULL
levels	NULL
of	NULL
high	NULL
and	NULL
low	NULL
affinity	NULL
IL-12	NULL
binding	NULL
were	NULL
measured	NULL
in	NULL
mouse	NULL
Thl	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
(	NULL
30	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
in	NULL
IL-	NULL
12	NULL
binding	NULL
behavior	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
systems	NULL
may	NULL
reflect	NULL
the	NULL
dominant	NULL
role	NULL
mouse	NULL
IL-	NULL
12R	NULL
B1	NULL
plays	NULL
in	NULL
binding	NULL
IL-12	NULL
(	NULL
34	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
humans	NULL
,	NULL
both	NULL
IL-12R	NULL
B1	NULL
and	NULL
B2	NULL
appear	NULL
to	NULL
contribute	NULL
equally	NULL
to	NULL
IL-12	NULL
binding	NULL
(	NULL
25	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
IL-	NULL
12R	NULL
B2	NULL
subunit	NULL
is	NULL
selectively	NULL
expressed	NULL
in	NULL
Th1	NULL
cells	NULL
where	NULL
it	NULL
is	NULL
induced	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
IL-12R	NULL
B2	NULL
chain	NULL
expression	NULL
could	NULL
be	NULL
the	NULL
reason	NULL
underlying	NULL
the	NULL
inability	NULL
of	NULL
IL-12	NULL
to	NULL
activate	NULL
the	NULL
Jak2-	NULL
Stat4	NULL
pathway	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

Regulation	NULL
of	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
Expression	NULL
during	NULL
T	NULL
Helper	NULL
Cell	NULL
Differentiation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-12	NULL
directly	NULL
influences	NULL
expression	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
,	NULL
we	NULL
added	NULL
IL-12	NULL
to	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
lines	NULL
at	NULL
day	NULL
19	NULL
after	NULL
priming	NULL
.	NULL

Culturing	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-	NULL
12	NULL
for	NULL
48	NULL
h	NULL
resulted	NULL
in	NULL
a	NULL
sevenfold	NULL
increase	NULL
in	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
in	NULL
Th1	NULL
lines	NULL
and	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
Th2	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
and	NULL
extended	NULL
using	NULL
established	NULL
Thl1	NULL
and	NULL
Th2	NULL
clones	NULL
.	NULL

IL-12	NULL
induced	NULL
IL-	NULL
12R	NULL
B2	NULL
mRNA	NULL
upregulation	NULL
(	NULL
threefold	NULL
)	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
experiments	NULL
revealed	NULL
that	NULL
the	NULL
IL-12	NULL
induced	NULL
upregulation	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
in	NULL
primed	NULL
T	NULL
cells	NULL
was	NULL
transient	NULL
;	NULL
maximal	NULL
induction	NULL
was	NULL
seen	NULL
24-48	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-12	NULL
,	NULL
but	NULL
returned	NULL
to	NULL
the	NULL
level	NULL
of	NULL
the	NULL
control	NULL
cultures	NULL
after	NULL
96	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
IL-12-induced	NULL
transient	NULL
upregulation	NULL
of	NULL
the	NULL
IL-	NULL
12R	NULL
B2	NULL
transcripts	NULL
in	NULL
Th2	NULL
clones	NULL
may	NULL
account	NULL
for	NULL
the	NULL
transient	NULL
period	NULL
of	NULL
IFN-y	NULL
production	NULL
in	NULL
cells	NULL
with	NULL
an	NULL
established	NULL
Th2	NULL
phenotype	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
IL-4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
the	NULL
development	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
into	NULL
Thl1	NULL
effectors	NULL
.	NULL

The	NULL
block	NULL
is	NULL
complete	NULL
if	NULL
IL-	NULL
12	NULL
is	NULL
not	NULL
present	NULL
in	NULL
the	NULL
priming	NULL
cul-ture	NULL
,	NULL
but	NULL
incomplete	NULL
if	NULL
IL-	NULL
12	NULL
is	NULL
present	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
found	NULL
that	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
IL-12	NULL
together	NULL
developed	NULL
into	NULL
cells	NULL
secreting	NULL
both	NULL
IL-4	NULL
(	NULL
1.1	NULL
ng/	NULL
ml	NULL
)	NULL
and	NULL
IFN-y	NULL
(	NULL
0.9	NULL
ng/	NULL
ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
phosphorylate	NULL
Stat4	NULL
in	NULL
Th2	NULL
Ko=2	NULL
nM	NULL
;	NULL
220	NULL
sites/cell	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Scatchard	NULL
analysis	NULL
of	NULL
[	NULL
'	NULL
»	NULL
IJIL-12	NULL
binding	NULL
to	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
lines	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Scatchard	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
[	NULL
'	NULL
``	NULL
IJlabeled	NULL
human	NULL
IL-12	NULL
binding	NULL
on	NULL
human	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
on	NULL
day	NULL
9	NULL
J	NULL
after	NULL
priming	NULL
as	NULL
described	NULL
in	NULL
Ma-*	NULL
terials	NULL
and	NULL
Methods	NULL
.	NULL

Comparable	NULL
0.06	NULL
0.003	NULL
Thi	NULL
K	NULL
,	NULL
=27	NULL
pM	NULL
;	NULL
140	NULL
sites/cell	NULL
K	NULL
,	NULL
=5	NULL
nM	NULL
;	NULL
450	NULL
sites/cell	NULL
*	NULL
0.04	NULL
0.002	NULL
us	NULL
us	NULL
co	NULL
Co	NULL
0.02	NULL
0.001	NULL
o	NULL
*	NULL
0	NULL
0	NULL
4	NULL
8	NULL
12	NULL
0	NULL
Bound	NULL
(	NULL
pM	NULL
)	NULL
[	NULL
[	NULL
»	NULL
IJIL-	NULL
12	NULL
binding	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independently	NULL
Bound	NULL
(	NULL
pM	NULL
)	NULL
derived	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
lines	NULL
.	NULL

828	NULL
_	NULL
Expression	NULL
of	NULL
IL-12	NULL
Receptors	NULL
during	NULL
T	NULL
Helper	NULL
Subset	NULL
Differentiation	NULL
A	NULL
IL-12/anti	NULL
IL-4	NULL
IL-4/anti	NULL
IL-12	NULL
IL-4/anti-lL-12	NULL
+	NULL
IFN-c.	NULL
IL-4/anti-lL-12	NULL
+	NULL
IFN-y	NULL
IL-4	NULL
+	NULL
IL-12	NULL
14	NULL
1.2	NULL
0.8	NULL
0.4	NULL
0	NULL
04	NULL
0.8	NULL
1.2	NULL
1.60	NULL
20	NULL
IFN-y	NULL
[	NULL
ng/ml	NULL
]	NULL
IL-4	NULL
[	NULL
ng/ml	NULL
]	NULL
B	NULL
x	NULL
Z	NULL
to	NULL
3	NULL
x	NULL
$	NULL
Ef	NULL
+	NULL
+	NULL
+	NULL
$	NULL
03	NULL
aw	NULL
a	NULL
a	NULL
#	NULL
3	NULL
3	NULL
3	NULL
3	NULL
9	NULL
EEE	NULL
a	NULL
m	NULL
©	NULL
©	NULL
s	NULL
+	NULL
Cytokines	NULL
added	NULL
Tov	NULL
¥	NULL
¥	NULL
¥	NULL
#	NULL
at	NULL
priming	NULL
-	NULL
<	NULL
2	NULL
2s	NULL
-	NULL
:	NULL
=	NULL
&	NULL
©	NULL
©	NULL
<	NULL
»	NULL
«	NULL
=-	NULL
IL-12R	NULL
B2	NULL
@	NULL
0	NULL
@	NULL
0	NULL
@	NULL
0	NULL
@	NULL
®	NULL
iss	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
C	NULL
3	NULL
ou	NULL
BJ	NULL
a	NULL
5	NULL
j	NULL
J	NULL
#	NULL
4	NULL
#	NULL
é	NULL
g	NULL
g	NULL
;	NULL
g	NULL
;	NULL
f	NULL
Cytoki	NULL
dded	NULL
a	NULL
C	NULL
£	NULL
&	NULL
ytokines	NULL
adde	NULL
a	NULL
$	NULL
$	NULL
%	NULL
$	NULL
%	NULL
$	NULL
atwiming	NULL
-	NULL
¥	NULL
L	NULL
£	NULL
oO	NULL
KT	NULL
€	NULL
£	NULL
U2	NULL
Blot	NULL
:	NULL
mon	NULL
mu	NULL
anti-P-¥	NULL
IP	NULL
:	NULL
anti-Stat4	NULL
crus	NULL
tose	NULL
gous	NULL
guns	NULL
gust	NULL
fort	NULL
cous	NULL
ames	NULL
dame	NULL
cmm	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Figure	NULL
6	NULL
.	NULL

Function	NULL
of	NULL
type	NULL
I	NULL
and	NULL
II	NULL
IFNs	NULL
in	NULL
the	NULL
development	NULL
of	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
and	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
.	NULL

(	NULL
4	NULL
)	NULL
IFN-a	NULL
«	NULL
induces	NULL
Th1	NULL
development	NULL
.	NULL

T	NULL
cell	NULL
lines	NULL
were	NULL
generated	NULL
by	NULL
stimulating	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
with	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
or	NULL
anti-cytokine	NULL
antibodies	NULL
.	NULL

IFN-	NULL
or	NULL
IFN-y	NULL
(	NULL
1,000	NULL
U/ml	NULL
!	NULL
)	NULL

were	NULL
added	NULL
at	NULL
the	NULL
time	NULL
of	NULL
priming	NULL
to	NULL
the	NULL
cultures	NULL
as	NULL
indicated	NULL
.	NULL

Cytokine	NULL
production	NULL
was	NULL
determined	NULL
on	NULL
day	NULL
10	NULL
.	NULL

IFN-a	NULL
«	NULL
,	NULL
but	NULL
not	NULL
IFN-y	NULL
,	NULL
induces	NULL
a	NULL
Th1	NULL
phenotype	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IFN-	NULL
«	NULL
induced	NULL
Th1	NULL
cells	NULL
express	NULL
IL-12R	NULL
B2	NULL
transcripts	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
T	NULL
cell	NULL
lines	NULL
10	NULL
d	NULL
after	NULL
priming	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
or	NULL
neutralizing	NULL
anti-cytokine	NULL
antibodies	NULL
.	NULL

R	NULL
Nase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

(	NULL
C	NULL
)	NULL
IFN-	NULL
«	NULL
induced	NULL
Th1	NULL
cells	NULL
are	NULL
IL-12	NULL
responsive	NULL
.	NULL

T	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
10	NULL
after	NULL
priming	NULL
.	NULL

8	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ng/ml	NULL
IL-12	NULL
in	NULL
1	NULL
ml	NULL
RPMI-FCS	NULL
.	NULL

IL-12	NULL
induced	NULL
Stat4	NULL
phosphorylation	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
above	NULL
.	NULL

829	NULL
_	NULL
Rogge	NULL
et	NULL
al	NULL
.	NULL

response	NULL
to	NULL
IL-12	NULL
and	NULL
accordingly	NULL
express	NULL
the	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lower	NULL
level	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
Thl	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neonatal	NULL
cells	NULL
primed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
neutralizing	NULL
anti-IL-12	NULL
mAb	NULL
completely	NULL
lost	NULL
IL-12R	NULL
B2	NULL
expression	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
A	NULL
and	NULL
6	NULL
B	NULL
)	NULL
and	NULL
consequently	NULL
,	NULL
IL-	NULL
12-mediated	NULL
signaling	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
6	NULL
C	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
IL-4	NULL
induces	NULL
the	NULL
generation	NULL
of	NULL
IL-12	NULL
nonresponsive	NULL
Th2	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
clarified	NULL
,	NULL
our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
IL-12	NULL
prevents	NULL
the	NULL
gradual	NULL
extinction	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
that	NULL
appears	NULL
to	NULL
follow	NULL
exposure	NULL
to	NULL
IL-4	NULL
.	NULL

Alterna-tively	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
or	NULL
IL-4	NULL
could	NULL
result	NULL
in	NULL
the	NULL
preferential	NULL
expansion	NULL
of	NULL
IL-	NULL
12	NULL
responsive	NULL
Th1	NULL
cells	NULL
or	NULL
IL-	NULL
12	NULL
nonresponsive	NULL
Th2	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

IFN	NULL
-a	NULL
Induces	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
Expression	NULL
and	NULL
IL-12	NULL
Responsiveness	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
In	NULL
addition	NULL
to	NULL
IL-12	NULL
,	NULL
IFN	NULL
-a	NULL
and	NULL
IFN-y	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
influence	NULL
Th1	NULL
cell	NULL
development	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
cytokines	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
expression	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IFN-a	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
as	NULL
well	NULL
as	NULL
IFN	NULL
-B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
to	NULL
human	NULL
cord	NULL
blood	NULL
leukocytes	NULL
stimulated	NULL
under	NULL
Th2-inducing	NULL
conditions	NULL
(	NULL
IL-4	NULL
and	NULL
anti-IL-12	NULL
mAb	NULL
)	NULL
resulted	NULL
in	NULL
cells	NULL
producing	NULL
IFN-y	NULL
(	NULL
>	NULL
1	NULL
ng/	NULL
ml	NULL
)	NULL
upon	NULL
restimulation	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

IL-12R	NULL
B2	NULL
mR	NULL
NA	NULL
was	NULL
expressed	NULL
in	NULL
the	NULL
IFN-o-treated	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
and	NULL
IL-12	NULL
induced	NULL
Stat4	NULL
phosphorylation	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
addition	NULL
of	NULL
IFN-y	NULL
to	NULL
cultures	NULL
containing	NULL
IL-4	NULL
and	NULL
anti-IL-12	NULL
(	NULL
Th2-inducing	NULL
con-ditions	NULL
)	NULL
or	NULL
addition	NULL
of	NULL
neutralizing	NULL
anti-IFN-y	NULL
mAb	NULL
at	NULL
the	NULL
time	NULL
of	NULL
Th1	NULL
priming	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
pattern	NULL
of	NULL
Th	NULL
cell	NULL
development	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
IL-	NULL
12R	NULL
B2	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

IFN-a	NULL
or	NULL
IFN-y	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-12R	NULL
B1	NULL
transcripts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

O	NULL
ur	NULL
findings	NULL
differ	NULL
from	NULL
previous	NULL
reports	NULL
showing	NULL
that	NULL
in	NULL
the	NULL
mouse	NULL
IFN-y	NULL
but	NULL
not	NULL
IFN	NULL
-a	NULL
influences	NULL
Th1	NULL
cell	NULL
development	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
,	NULL
together	NULL
with	NULL
the	NULL
evidence	NULL
that	NULL
IFN	NULL
-a	NULL
in	NULL
vitro	NULL
favors	NULL
the	NULL
development	NULL
of	NULL
human	NULL
allergen-specific	NULL
T	NULL
cells	NULL
into	NULL
a	NULL
Thl	NULL
phenotype	NULL
(	NULL
37	NULL
)	NULL
,	NULL
suggest	NULL
that	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IFN	NULL
s	NULL
could	NULL
have	NULL
different	NULL
functional	NULL
effects	NULL
on	NULL
human	NULL
as	NULL
compared	NULL
to	NULL
mouse	NULL
T	NULL
cells	NULL
Indeed	NULL
,	NULL
preliminary	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
human	NULL
Th2	NULL
cells	NULL
,	NULL
both	NULL
IFN-a	NULL
«	NULL
and	NULL
IFN-B	NULL
are	NULL
able	NULL
to	NULL
induce	NULL
a	NULL
much	NULL
stronger	NULL
(	NULL
10-fold	NULL
higher	NULL
)	NULL
phosphorylation	NULL
of	NULL
Stat1	NULL
as	NULL
compared	NULL
to	NULL
IFN-y	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
quantitative	NULL
rather	NULL
than	NULL
a	NULL
qualitatitive	NULL
difference	NULL
in	NULL
IFN-induced	NULL
signaling	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
cells	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
major	NULL
signaling	NULL
pathways	NULL
influencing	NULL
IL-12R	NULL
B2	NULL
expression	NULL
.	NULL

Triggering	NULL
of	NULL
the	NULL
antigen	NULL
receptor	NULL
on	NULL
naive	NULL
T	NULL
cells	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
initial	NULL
expression	NULL
of	NULL
functional	NULL
IL-	NULL
12	NULL
receptors	NULL
on	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
cytokines	NULL
present	NULL
during	NULL
the	NULL
differentiation	NULL
,	NULL
T	NULL
cells	NULL
will	NULL
then	NULL
develop	NULL
into	NULL
IL-	NULL
12-respon-sive	NULL
Th1	NULL
cells	NULL
or	NULL
IL-12-nonresponsive	NULL
Th2	NULL
cells	NULL
Analysis	NULL
of	NULL
the	NULL
IL-12R	NULL
B2	NULL
promoter	NULL
should	NULL
provide	NULL
insights	NULL
into	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
TCR	NULL
triggering	NULL
and	NULL
signals	NULL
mediated	NULL
by	NULL
IL-12	NULL
,	NULL
IFN-a	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
other	NULL
cytokines	NULL
are	NULL
integrated	NULL
to	NULL
regulate	NULL
IL-12R	NULL
B2	NULL
chain	NULL
expression	NULL
.	NULL

The	NULL
IL-12R	NULL
B2	NULL
chain	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
first	NULL
Th1	NULL
subset-specific	NULL
noncytokine	NULL
gene	NULL
to	NULL
be	NULL
identified	NULL
to	NULL
date	NULL
.	NULL

Here	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
IFN	NULL
-a	NULL
,	NULL
but	NULL
not	NULL
IFN-y	NULL
,	NULL
can	NULL
induce	NULL
Th1	NULL
development	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Th2-inducing	NULL
cytokine	NULL
IL-4	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
IL-	NULL
12	NULL
and	NULL
IFN-a	NULL
«	NULL
,	NULL
by	NULL
inducing	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
B2	NULL
component	NULL
of	NULL
the	NULL
IL-12R	NULL
after	NULL
antigen	NULL
receptor	NULL
triggering	NULL
,	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
both	NULL
the	NULL
functional	NULL
activ-	NULL
ity	NULL
and	NULL
development	NULL
of	NULL
Th1	NULL
cells	NULL
The	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
events	NULL
controlling	NULL
T	NULL
cell	NULL
development	NULL
may	NULL
allow	NULL
the	NULL
selective	NULL
manipulation	NULL
of	NULL
Th	NULL
subsets	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
possibility	NULL
of	NULL
forcing	NULL
expression	NULL
in	NULL
vivo	NULL
of	NULL
the	NULL
IL-	NULL
12R	NULL
B2	NULL
by	NULL
IFN	NULL
-a	NULL
or	NULL
IL-	NULL
12	NULL
treatment	NULL
,	NULL
for	NULL
example	NULL
,	NULL
could	NULL
have	NULL
important	NULL
therapeutic	NULL
implications	NULL
in	NULL
Th2-mediated	NULL
pathological	NULL
conditions	NULL
,	NULL
such	NULL
as	NULL
allergies	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
M.	NULL
Gately	NULL
for	NULL
the	NULL
IL-12	NULL
and	NULL
anti-IL-12	NULL
antibodies	NULL
,	NULL
H.	NULL
Gallati	NULL
and	NULL
R.	NULL
Lang	NULL
for	NULL
the	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
ELISA	NULL
assays	NULL
,	NULL
P.	NULL
Vigano	NULL
for	NULL
the	NULL
cord	NULL
blood	NULL
samples	NULL
,	NULL
R.	NULL
Pardi	NULL
for	NULL
the	NULL
mAbs	NULL
,	NULL
R.	NULL
Germain	NULL
and	NULL
E.	NULL
Bianchi	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
K.	NULL
Murphy	NULL
for	NULL
communicating	NULL
results	NULL
before	NULL
publi-	NULL
cation	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Lars	NULL
R	NULL
ogge	NULL
or	NULL
Francesco	NULL
Sinigaglia	NULL
,	NULL
Roche	NULL
Milano	NULL
Ricerche	NULL
,	NULL
Via	NULL
Olgettina	NULL
58	NULL
,	NULL
I-20132	NULL
Milano	NULL
,	NULL
Italy	NULL
.	NULL

L.	NULL
Barberis	NULL
Maino	NULL
's	NULL
present	NULL
address	NULL
is	NULL
Institute	NULL
for	NULL
Molecular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Ziirich	NULL
,	NULL
W	NULL
interthurerstrasse	NULL
190	NULL
,	NULL
8057	NULL
Ziirich	NULL
,	NULL
Switzerland	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
2	NULL
December	NULL
1996	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Coffman	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
D.A	NULL
.	NULL

Lebman	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
mechanism	NULL
and	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
isotype	NULL
switch-ing	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

54:228-269	NULL
.	NULL

2	NULL
.	NULL

Seder	NULL
,	NULL
R.A.	NULL
,	NULL
and	NULL
W.E	NULL
.	NULL

Paul	NULL
.	NULL

1994	NULL
.	NULL

Acquisition	NULL
of	NULL
lymphokine-producing	NULL
phenotype	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:635-673	NULL
.	NULL

3	NULL
.	NULL

Romagnani	NULL
,	NULL
S.	NULL
1994	NULL
.	NULL

Lymphokine	NULL
production	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
disease	NULL
states	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:227-257	NULL
.	NULL

4	NULL
.	NULL

Abbas	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
KM	NULL
.	NULL

Murphy	NULL
,	NULL
and	NULL
A.	NULL
Sher	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
diversity	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
.	NULL

Natwe	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

383:787-793	NULL
.	NULL

5	NULL
.	NULL

Seder	NULL
,	NULL
R.A.	NULL
,	NULL
W.E	NULL
.	NULL

Paul	NULL
,	NULL
M.M	NULL
.	NULL

Davis	NULL
,	NULL
and	NULL
B.F.	NULL
de	NULL
St.	NULL
Groth	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
interleukin-4	NULL
during	NULL
in	NULL
vitro	NULL
priming	NULL
determines	NULL
the	NULL
lymphokine-producing	NULL
potential	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
T	NULL
cell	NULL
receptor	NULL
transgenic	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
:	NULL
1091-1098	NULL
.	NULL

6	NULL
.	NULL

Hsieh	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
A.B	NULL
.	NULL

Heimberger	NULL
,	NULL
J.S	NULL
.	NULL

Gold	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
and	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1992	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
T	NULL
helper	NULL
phenotype	NULL
development	NULL
by	NULL
interleukins	NULL
4	NULL
and	NULL
10	NULL
in	NULL
an	NULL
alpha	NULL
beta	NULL
T	NULL
cell-receptor	NULL
transgenic	NULL
system	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

89:6065-6069	NULL
.	NULL

7	NULL
.	NULL

Hsieh	NULL
,	NULL
C.-S.	NULL
,	NULL
S.E	NULL
.	NULL

Macatonia	NULL
,	NULL
C.S	NULL
.	NULL

Tripp	NULL
,	NULL
SF	NULL
.	NULL

Wolf	NULL
,	NULL
A.	NULL
O	NULL
'Garra	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1993	NULL
.	NULL

Development	NULL
of	NULL
Ty1	NULL
CD4	NULL
#	NULL
+	NULL
T	NULL
cells	NULL
through	NULL
IL-12	NULL
produced	NULL
by	NULL
Listeria-	NULL
induced	NULL
macro-phages	NULL
.	NULL

Sdene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

260:547-549	NULL
.	NULL

8	NULL
.	NULL

Manetti	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Parronchi	NULL
,	NULL
M.G	NULL
.	NULL

Giudizi	NULL
,	NULL
M.-P.	NULL
Piccinni	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
G.	NULL
Trinchieri	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1993	NULL
.	NULL

Natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
interleukin	NULL
12	NULL
[	NULL
IL-12	NULL
]	NULL
)	NULL
induces	NULL
T	NULL
helper	NULL
1	NULL
type	NULL
(	NULL
Th1	NULL
)	NULL
-specific	NULL
immune	NULL
responses	NULL
and	NULL
inhibits	NULL
the	NULL
development	NULL
of	NULL
IL-4-producing	NULL
Th	NULL
cells	NULL
J	NULL
Exp	NULL
.	NULL

Med	NULL
177:1199-1204	NULL
.	NULL

9	NULL
.	NULL

Seder	NULL
,	NULL
R.A.	NULL
,	NULL
R.	NULL
Gazzinelli	NULL
,	NULL
A.	NULL
Sher	NULL
,	NULL
and	NULL
W.E	NULL
.	NULL

Paul	NULL
.	NULL

1993	NULL
.	NULL

IL-12	NULL
acts	NULL
directly	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
to	NULL
enhance	NULL
priming	NULL
for	NULL
interferon	NULL
y	NULL
production	NULL
and	NULL
diminishes	NULL
interleukin	NULL
4	NULL
inhibition	NULL
of	NULL
such	NULL
priming	NULL
.	NULL

Proc	NULL
Natl	NULL
Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

90:10188-10192	NULL
.	NULL

10	NULL
.	NULL

Magram	NULL
,	NULL
J.	NULL
,	NULL
S.E	NULL
.	NULL

Connaughton	NULL
,	NULL
R.R	NULL
.	NULL

Warrier	NULL
,	NULL
D.M	NULL
.	NULL

Carva-jal	NULL
,	NULL
C.-Y	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
Ferrante	NULL
,	NULL
C.	NULL
Stewart	NULL
,	NULL
U.	NULL
Sarimiento	NULL
,	NULL
D.A	NULL
.	NULL

Faherty	NULL
,	NULL
and	NULL
M.K	NULL
.	NULL

Gately	NULL
.	NULL

1996	NULL
.	NULL

IL-	NULL
12	NULL
deficient	NULL
mice	NULL
are	NULL
defective	NULL
in	NULL
IFNy	NULL
production	NULL
and	NULL
type	NULL
I	NULL
cytokine	NULL
responses	NULL
.	NULL

Immunity	NULL
.	NULL

4:471-481	NULL
.	NULL

11	NULL
.	NULL

Kiihn	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Rajewsky	NULL
,	NULL
and	NULL
W.	NULL
Miller	NULL
.	NULL

1991	NULL
.	NULL

Generation	NULL
and	NULL
analysis	NULL
of	NULL
interleukin-4-deficient	NULL
mice	NULL
.	NULL

Saene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

254:707-710	NULL
.	NULL

12	NULL
.	NULL

Kopf	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Le	NULL
Gros	NULL
,	NULL
M.	NULL
Bachmann	NULL
,	NULL
M.C	NULL
.	NULL

Lamers	NULL
,	NULL
H.	NULL
Bluethmann	NULL
,	NULL
and	NULL
G.	NULL
Kohler	NULL
.	NULL

1993	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
blocks	NULL
Th2	NULL
cytokine	NULL
responses	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

362	NULL
:	NULL
245-248	NULL
.	NULL

13	NULL
.	NULL

Kaplan	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
U.	NULL
Schindler	NULL
,	NULL
S.T	NULL
.	NULL

Smiley	NULL
,	NULL
and	NULL
M.J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
.	NULL

4:313-319	NULL
.	NULL

14	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
W.	NULL
Shi	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Minami	NULL
,	NULL
S.-I	NULL
.	NULL

Kashiwamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1996	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signalling	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

380:627-630	NULL
.	NULL

15	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
van	NULL
Deursen	NULL
,	NULL
M.Y	NULL
.	NULL

Sangster	NULL
,	NULL
SR.	NULL
Sarawar	NULL
,	NULL
R.T.	NULL
Carson	NULL
,	NULL
R.A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
FW	NULL
.	NULL

Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.A.A	NULL
.	NULL

Vignalli	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

380:630-633	NULL
.	NULL

16	NULL
.	NULL

Thierfelder	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
J.M	NULL
.	NULL

van	NULL
Deursen	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
R.A.	NULL
Tripp	NULL
,	NULL
SR.	NULL
Sarawar	NULL
,	NULL
R.T.	NULL
Carson	NULL
,	NULL
M.Y	NULL
.	NULL

Sangster	NULL
,	NULL
D.A.A	NULL
.	NULL

Vignali	NULL
,	NULL
P.C	NULL
.	NULL

Doherty	NULL
,	NULL
G.C	NULL
.	NULL

Grosveld	NULL
,	NULL
and	NULL
J.N	NULL
.	NULL

Ihle	NULL
.	NULL

1996	NULL
.	NULL

Requirement	NULL
for	NULL
Stat4	NULL
in	NULL
interleukin-	NULL
12-mediated	NULL
responses	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cells	NULL
Natwre	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

382:171-174	NULL
.	NULL

17	NULL
.	NULL

Kaplan	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
M.J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Impaired	NULL
IL-	NULL
12	NULL
responses	NULL
and	NULL
enhanced	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
in	NULL
Stat4-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

382:174-177	NULL
.	NULL

18	NULL
.	NULL

Coligan	NULL
,	NULL
JE	NULL
.	NULL

,	NULL
A.M.	NULL
Kruisbeek	NULL
,	NULL
D.H.	NULL
Margulies	NULL
,	NULL
EM	NULL
.	NULL

She-vach	NULL
,	NULL
and	NULL
W.	NULL
Strober	NULL
.	NULL

1991	NULL
.	NULL

Current	NULL
Protocols	NULL
in	NULL
Immunol-ogy	NULL
.	NULL

Ist	NULL
ed	NULL
.	NULL

Greene	NULL
&	NULL
Wiley	NULL
,	NULL
New	NULL
York	NULL
.	NULL

7.1-7.8	NULL
.	NULL

19	NULL
.	NULL

Lanzavecchia	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Scheidegger	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
use	NULL
of	NULL
hybrid	NULL
hybridomas	NULL
to	NULL
target	NULL
human	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

17:105-111	NULL
.	NULL

20	NULL
.	NULL

Gallati	NULL
,	NULL
H.	NULL
,	NULL
I.	NULL
Pracht	NULL
,	NULL
J.	NULL
Schmidt	NULL
,	NULL
P.	NULL
Hiring	NULL
,	NULL
and	NULL
G.	NULL
Garotta	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
simple	NULL
,	NULL
rapid	NULL
and	NULL
large	NULL
capacity	NULL
ELISA	NULL
for	NULL
biologically	NULL
active	NULL
native	NULL
and	NULL
recombinant	NULL
human	NULL
IFN-y	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Regul	NULL
.	NULL

Homeostatic	NULL
A	NULL
gents	NULL
.	NULL

1:109-118	NULL
.	NULL

21	NULL
.	NULL

Perussia	NULL
B.	NULL
,	NULL
S.	NULL
Starr	NULL
,	NULL
S.	NULL
Abraham	NULL
,	NULL
V.	NULL
Fanning	NULL
,	NULL
and	NULL
G.	NULL
830	NULL
_	NULL
Expression	NULL
of	NULL
IL-12	NULL
Receptors	NULL
during	NULL
T	NULL
Helper	NULL
Subset	NULL
Differentiation	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Trinchieri	NULL
.	NULL

1983	NULL
.	NULL

Human	NULL
natural	NULL
killer	NULL
cells	NULL
analyzed	NULL
by	NULL
B73.1	NULL
,	NULL
a	NULL
monoclonal	NULL
antibody	NULL
blocking	NULL
Fc	NULL
receptor	NULL
func-tions	NULL
.	NULL

I	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
lymphocyte	NULL
subset	NULL
reactive	NULL
with	NULL
B73.1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

130:2133-2139	NULL
.	NULL

Norton	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
A.D.	NULL
Ramsay	NULL
,	NULL
S.H	NULL
.	NULL

Smith	NULL
,	NULL
P.C.L	NULL
.	NULL

Beverly	NULL
,	NULL
and	NULL
P.G	NULL
.	NULL

Isaacson	NULL
.	NULL

1986	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
(	NULL
UCHL-1	NULL
)	NULL
that	NULL
recognizes	NULL
normal	NULL
and	NULL
neoplastic	NULL
T	NULL
cells	NULL
in	NULL
fixed	NULL
tissues	NULL
.	NULL

J	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

39:399-405	NULL
.	NULL

Cammarota	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Scheirle	NULL
,	NULL
B.	NULL
Takacs	NULL
,	NULL
D.M	NULL
.	NULL

Doran	NULL
,	NULL
R.	NULL
Knorr	NULL
,	NULL
W.	NULL
Bannwarth	NULL
,	NULL
J.	NULL
Guardiola	NULL
,	NULL
and	NULL
F.	NULL
Sinigaglia	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
CD4	NULL
binding	NULL
site	NULL
on	NULL
the	NULL
B	NULL
,	NULL
domain	NULL
of	NULL
HLA-DR	NULL
molecules	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:799-801	NULL
.	NULL

Sinigaglia	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
Romagnoli	NULL
,	NULL
M.	NULL
Guttinger	NULL
,	NULL
B.	NULL
Takacs	NULL
,	NULL
and	NULL
JR.P	NULL
.	NULL

Pink	NULL
.	NULL

1991	NULL
.	NULL

Selection	NULL
of	NULL
T	NULL
cell	NULL
epitopes	NULL
and	NULL
vaccine	NULL
engineering	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

203:370-386	NULL
.	NULL

Presky	NULL
,	NULL
D.H.	NULL
,	NULL
H.	NULL
Yang	NULL
,	NULL
LJ	NULL
.	NULL

Minetti	NULL
,	NULL
A.0	NULL
.	NULL

Chua	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
C.-Y	NULL
.	NULL

Wu	NULL
,	NULL
M.K	NULL
.	NULL

Gately	NULL
,	NULL
and	NULL
U.	NULL
Gubler	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
functional	NULL
interleukin-	NULL
12	NULL
receptor	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
B	NULL
type	NULL
cytokine	NULL
receptor	NULL
subunits	NULL
Proc	NULL
Natl	NULL
Aad	NULL
Sd	NULL
.	NULL

USA	NULL
.	NULL

93	NULL
:	NULL
14002-14007	NULL
.	NULL

Chua	NULL
,	NULL
A.0O	NULL
.	NULL

,	NULL
R.	NULL
Chizzonite	NULL
,	NULL
B.B	NULL
.	NULL

Desai	NULL
,	NULL
TP	NULL
.	NULL

Truitt	NULL
,	NULL
P.	NULL
Nunes	NULL
,	NULL
LJ	NULL
.	NULL

Minetti	NULL
,	NULL
R.R	NULL
.	NULL

Warrier	NULL
,	NULL
D.H.	NULL
Presky	NULL
,	NULL
J.F	NULL
.	NULL

Levine	NULL
,	NULL
MK	NULL
.	NULL

Gately	NULL
,	NULL
and	NULL
U.	NULL
Gubler	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
a	NULL
human	NULL
IL-	NULL
12	NULL
receptor	NULL
component	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
with	NULL
strong	NULL
homology	NULL
to	NULL
gp130	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:128-136	NULL
.	NULL

Passini	NULL
,	NULL
N.	NULL
,	NULL
J.D	NULL
.	NULL

Larigan	NULL
,	NULL
S.	NULL
Genovese	NULL
,	NULL
E.	NULL
Appella	NULL
,	NULL
F.	NULL
Sinigaglia	NULL
,	NULL
and	NULL
L.	NULL
Rogge	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
37/40-kilodalton	NULL
autoantigen	NULL
in	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
is	NULL
the	NULL
putative	NULL
tyrosine	NULL
phosphatase	NULL
IA-2	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

92:9412-9416	NULL
.	NULL

Chizzonite	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
Truitt	NULL
,	NULL
B.B	NULL
.	NULL

Desai	NULL
,	NULL
P.	NULL
Nunes	NULL
,	NULL
F.J.	NULL
Pod-laski	NULL
,	NULL
A.S.	NULL
Stern	NULL
,	NULL
and	NULL
MK	NULL
.	NULL

Gately	NULL
.	NULL

1992	NULL
.	NULL

IL-12	NULL
receptor	NULL
.	NULL

I	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
receptor	NULL
on	NULL
phytohemagglutinin-activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

148:3117-3124	NULL
.	NULL

McPherson	NULL
,	NULL
G.A	NULL
.	NULL

1985	NULL
.	NULL

Analysis	NULL
of	NULL
radioligand	NULL
binding	NULL
experiments	NULL
.	NULL

A	NULL
collection	NULL
of	NULL
computer	NULL
programs	NULL
for	NULL
the	NULL
IBM	NULL
PC	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Methods	NULL
.	NULL

14:213-228	NULL
.	NULL

Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
N.G	NULL
.	NULL

Jacobson	NULL
,	NULL
A.S.	NULL
Dighe	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
and	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1995	NULL
.	NULL

Developmental	NULL
commitment	NULL
to	NULL
the	NULL
Th2	NULL
lin	NULL
831	NULL
R	NULL
ogge	NULL
et	NULL
al	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38.	NULL
eage	NULL
by	NULL
extinction	NULL
of	NULL
IL-12	NULL
signaling	NULL
.	NULL

Immunity	NULL
.	NULL

2:665-675	NULL
.	NULL

Bacon	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
E.F.	NULL
Petricoin	NULL
III	NULL
,	NULL
JR.	NULL
Ortaldo	NULL
,	NULL
R.C	NULL
.	NULL

Rees	NULL
,	NULL
A.C.	NULL
Larner	NULL
,	NULL
J.A	NULL
.	NULL

Johnston	NULL
,	NULL
and	NULL
J.J.	NULL
O'Shea	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STAT4	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sd	NULL
.	NULL

USA	NULL
.	NULL

92:7307-7311	NULL
.	NULL

Jacobson	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
S.J	NULL
.	NULL

Szabo	NULL
,	NULL
R.N	NULL
.	NULL

Weber-Nordt	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
R.D	NULL
.	NULL

Schreiber	NULL
,	NULL
J.E	NULL
.	NULL

Darnell	NULL
,	NULL
and	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
signaling	NULL
in	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
3	NULL
and	NULL
4	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1755-1762	NULL
.	NULL

Bacon	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
D.W.	NULL
McVicar	NULL
,	NULL
J.R.	NULL
Ortaldo	NULL
,	NULL
R.C	NULL
.	NULL

Rees	NULL
,	NULL
J.J.	NULL
O'Shea	NULL
,	NULL
and	NULL
J.A	NULL
.	NULL

Johnston	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
(	NULL
IL-12	NULL
)	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
and	NULL
Tyk2	NULL
:	NULL
differential	NULL
use	NULL
of	NULL
Janus	NULL
family	NULL
tyrosine	NULL
kinases	NULL
by	NULL
IL-2	NULL
and	NULL
IL-	NULL
12	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:399-404	NULL
.	NULL

Chua	NULL
,	NULL
A.0	NULL
.	NULL

,	NULL
V.L	NULL
.	NULL

Wilkinson	NULL
,	NULL
D.H.	NULL
Presky	NULL
,	NULL
and	NULL
U.	NULL
Gubler	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
mouse	NULL
IL-12	NULL
recep-tor-beta	NULL
component	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

155:4286-4294	NULL
.	NULL

Manetti	NULL
,	NULL
R.	NULL
,	NULL
F.	NULL
Gerosa	NULL
,	NULL
M.G	NULL
.	NULL

Giudizi	NULL
,	NULL
R.	NULL
Biagiotti	NULL
,	NULL
P.	NULL
Parronchi	NULL
,	NULL
M.-P.	NULL
Piccinni	NULL
,	NULL
S.	NULL
Sampognaro	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
S.	NULL
Romagnani	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
stable	NULL
priming	NULL
for	NULL
interferon	NULL
y	NULL
(	NULL
IFN-y	NULL
)	NULL
production	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
and	NULL
transient	NULL
IFN-y	NULL
production	NULL
in	NULL
established	NULL
Th2	NULL
cell	NULL
clones	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
:	NULL
1273-1283	NULL
.	NULL

Yssel	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Fasler	NULL
,	NULL
J.E	NULL
.	NULL

de	NULL
Vries	NULL
,	NULL
and	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
.	NULL

1994	NULL
.	NULL

IL-	NULL
12	NULL
transiently	NULL
induces	NULL
IFN-y	NULL
transcription	NULL
and	NULL
protein	NULL
synthesis	NULL
in	NULL
human	NULL
CD4*	NULL
allergen-specific	NULL
Th2	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:1091-1096	NULL
.	NULL

Parronchi	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Mohapatra	NULL
,	NULL
S.	NULL
Sampognaro	NULL
,	NULL
L.	NULL
Giannarini	NULL
,	NULL
U.	NULL
Wahn	NULL
,	NULL
P.	NULL
Chong	NULL
,	NULL
S.	NULL
Mohapatra	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
H.	NULL
Renz	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
of	NULL
interferon-	NULL
on	NULL
cytokine	NULL
profile	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
repertoire	NULL
and	NULL
peptide	NULL
reactivity	NULL
of	NULL
human	NULL
allergen-specific	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:697-703	NULL
.	NULL

Wenner	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
M.L	NULL
.	NULL

Giiler	NULL
,	NULL
S.E	NULL
.	NULL

Macatonia	NULL
,	NULL
A.	NULL
O	NULL
'Garra	NULL
,	NULL
and	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1996	NULL
.	NULL

Roles	NULL
of	NULL
IFN-y	NULL
and	NULL
IFN-a	NULL
«	NULL
in	NULL
IL-12	NULL
induced	NULL
T	NULL
helper	NULL
cell-1	NULL
development	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1156:1442-1447	NULL
.	NULL

